Market Place
Sourcing Support
Transo-Pharm becomes green...or blue?
19 Aug 2024 //
PRESS RELEASE
Transo-Pharm Expands Portfolio Welcome on board, Norepinephrine Bitartrate
29 Jul 2024 //
PRESS RELEASE
In memory of Artan "Tani" Bekteshi
27 Jun 2024 //
PRESS RELEASE
Transo-Pharm Guarantees Uninterrupted Epinephrine Supply
28 Mar 2024 //
PRESS RELEASE
BAFA - 15th Export Control Information Day
01 Feb 2024 //
PRESS RELEASE
Further extension of validity of GMP certificates up to end of 2024
14 Dec 2023 //
PRESS RELEASE
EU Commission fines pharma companies for price fixing
19 Oct 2023 //
REUTERS
New Sales staff at Transo-Pharm
10 Oct 2023 //
PRESS RELEASE
Stephanie Ehlers will leave Transo-Pharm by the end of this month
21 Mar 2023 //
PRESS RELEASE
Transo-Pharm Partners With 22nd Century For Global Cannabinoid API Distribution
23 Jan 2023 //
PRESS RELEASE
Extended validity of GMP certificates up to end of 2023
16 Jan 2023 //
PRESS RELEASE
CPHI Frankfurt 2022
22 Nov 2022 //
PRESS RELEASE
Transo-Pharm in Crete
15 Nov 2022 //
PRESS RELEASE
Epinephrine - Supply Continuity Program
19 Oct 2022 //
PRESS RELEASE
HAPILA and Transo-Pharm together at CPHI Frankfurt 2022 - booth 110D20
23 Sep 2022 //
PRESS FRELEASE
After work“ at Transo-Pharm
29 Jun 2022 //
PRESS RELEASE
Providing regulatory documents - request form
22 Mar 2022 //
PRESS RELEASE
New European Dual-Use Regulation
21 Feb 2022 //
PRESS RELEASE
Online Remote Audit at Transo-Pharm
27 Jan 2022 //
PRESS RELEASE
HAPILA and Transo-Pharm expand cooperation
12 Jan 2022 //
PRESS RELEASE
Shoe-Yin "Abing" Bieber
01 Dec 2021 //
PRESS RELEASE
In times of Covid-19
15 Nov 2021 //
PRESS RELEASE
Andreas Freihse
26 Oct 2021 //
PRESS RELEASE
With mixed feelings we have to announce that assignment of Oliver Lohmann ended
16 Jul 2021 //
PRESS RELEASE
Update: Fire at Syn-Tech in Taiwan
25 Jun 2021 //
PRESS RELEASE
Workplace concept at Transo-Pharm during the Corona Pandemic
12 Apr 2021 //
PRESS RELEASE
A hot blog about Nonivamide
11 Mar 2021 //
PRESS RELEASE
Apprenticeship program at Transo-Pharm during the COVID-19 pandemic
05 Feb 2021 //
PRESS RELEASE
Transo-Pharm`s succesful co-operation with the USP
13 Jan 2021 //
PRESS RELEASE
Qiang Chen. Johnny, passed away
11 Nov 2020 //
PRESS RELEASE
Epinephrine Base & Bitartrate
14 Oct 2020 //
PRESS RELEASE
Scientific and Regulatory Support at Transo-Pharm
23 Sep 2020 //
PRESS RELEASE
Digitalis – the source for a life-saving API
04 Sep 2020 //
PRESS RELEASE
Digoxin from Alkaloids Corporation - CEP now includes micronized material
19 Jun 2020 //
PRESS RELEASE
Enantiomeric purity – & the associated advantages of Transo-Pharm’s Epinephrine
29 May 2020 //
PRESS RELEASE
Adrenaline base and tartrate – DMF filing in Brazil
06 May 2020 //
PRESS RELEASE
Epinephrine Base & Bitartrate Supply Chain and the Corona crisis
26 Mar 2020 //
PRESS RELEASE
Coronavirus Statement- Transo-Pharm continues to closely monitor the impact
18 Mar 2020 //
PRESS RELEASE
Update: Coronavirus news - Epinephrine / Phenylephrine
09 Mar 2020 //
PRESS RELEASE
Nitrosamine risk evaluation
28 Feb 2020 //
PRESS RELEASE
Coronavirus Update - Supply chain disruption
31 Jan 2020 //
PRESS RELEASE
Adrenaline CEP`s: out of range country acceptance
15 Jan 2020 //
PRESS RELEASE
Scopolamine Base, Hydrobromide & Methylbromide - niche Phyto API’s from Transo-Pharm
27 Aug 2019 //
PRESS RELEASE
